Marie Austdal

Stavanger, 4011, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

Journal: Cancers

Published: February 01, 2026

Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Journal: Clinical and experimental medicine

Published: December 05, 2025

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Journal: Molecular oncology

Published: May 02, 2025

Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes.

Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes.

Journal: Frontiers in immunology

Published: October 07, 2024

Integrating Genetic Alterations and Histopathological Features for Enhanced Risk Stratification in Non-Muscle-Invasive Bladder Cancer.

Integrating Genetic Alterations and Histopathological Features for Enhanced Risk Stratification in Non-Muscle-Invasive Bladder Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: September 02, 2024

New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.

New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.

Journal: Frontiers in immunology

Published: March 01, 2024

Quantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients.

Quantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients.

Journal: Clinical proteomics

Published: December 06, 2023

Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid.

Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 25, 2023

Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.

Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 18, 2023

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins.

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins.

Journal: Metabolites

Published: February 25, 2023

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 15, 2022

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.

Journal: BMJ open

Published: April 29, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026